Stay updated on Tagraxofusp in Secondary AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record history now includes a new revision entry v3.6.5. The previous revision v3.6.4 has been removed.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new Revision: v3.6.4 entry was added and the previous Revision: v3.6.3 entry was removed in the study record history, indicating a small backend/UI update reflected in the log.SummaryDifference0.1%

- Check43 days agoChange DetectedThe history section now includes new entries for eligibility and study status, with a latest version noted as 27 around 2026-07-09 and an entry for 2026-07-10; an older entry from 2026-04-08 has been removed.SummaryDifference0.4%

- Check50 days agoChange DetectedRevision label updated to v3.6.3 in the page history, replacing the previous v3.6.2. This reflects a minor update to the page rendering or metadata for the study record, without changes to the study data.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page history now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects an update to the record history’s versioning metadata.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded Check who can join and Find Contact Information, plus a Revision: v3.6.0 note in the history view. These updates reflect UI and documentation changes that improve access to recruitment information and staff contact details, while recording the latest platform release.SummaryDifference0.4%

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.